Histopathological evaluation through HE staining and immunohistochemical profiling demonstrated that FBZ treatment induced extensive tumor necrosis while suppressing proliferative (Ki67) and metastatic (ROCK1) markers in xenograft tissues. The gene discussed is MKI67; the disease is neoplasm.